logo

For the Inventor, By the Inventor

Northborough, MA, United States of America

Lu Wang

This inventor holds 11 USPTO granted patents and 17 published patent applications and 4 EPO patents. Top assignees: Abbvie Inc., Abbott Laboratories Corporation, Other. Active years: 2011-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lu Wang. Retrieved from https://idiyas.com/inventor/lu-wang-x4qcfwtt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 81.8

 

Average Co-Inventor Count = 11.0

ph-index = 7

Forward Citations = 348(Granted Patents)


Location History:

  • Worcester, MA (US) (2014)
  • Northborough, MA (US) (2011 - 2020)
  • Westborough, MA (US) (2015 - 2020)

Company Filing History:

goldMedal9 out of 826 
 
Abbvie Inc.
 patents
silverMedal1 out of 4,187 
 
Abbott Laboratories Corporation
 patents
bronzeMedal1 out of 834,453 
Other
 patents

Years Active: 2011-2020

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 10772970 - Glucocorticoid receptor agonist and immunoconjugates thereof (2020-09-15),
2. 9567339 - Primary carboxamides as BTK inhibitors (2017-02-14),
3. 9365579 - Tricyclic compounds (2016-06-14),
4. 9163007 - 5-substituted indazoles as kinase inhibitors (2015-10-20),
5. 8962629 - Tricyclic compounds (2015-02-24),
6. 8785639 - Substituted dihydropyrazolo[3,4-D]pyrrolo[2,3-B]pyridines and methods of use thereof (2014-07-22),
7. 8754107 - Aminopyrrolidines as chemokine receptor antagonists (2014-06-17),
8. 8648069 - 5-substituted indazoles as kinase inhibitors (2014-02-11),
9. 8598199 - Octahydropentalene compounds as chemokine receptor antagonists (2013-12-03),
10. 8008481 - Indazole compounds (2011-08-30),
11. 7939544 - Octahydropentalene compounds as chemokine receptor antagonists (2011-05-10),

Title: Lu Wang: Innovator in Immunology and Oncology

Introduction

Lu Wang is a prominent inventor based in Northborough, MA (US), known for his significant contributions to the fields of immunology and oncology. With a total of 11 patents to his name, Wang has made remarkable strides in developing innovative therapeutic solutions.

Latest Patents

Among his latest patents, Wang has developed glucocorticoid receptor agonist immunoconjugates, which provide new methods for utilizing glucocorticoid receptor agonists. Additionally, he has created primary carboxamides as BTK inhibitors, offering compounds that are useful for treating various immunological and oncological conditions.

Career Highlights

Wang has worked with notable companies, including AbbVie Inc., where he has contributed to groundbreaking research and development in his field. His work has been instrumental in advancing therapeutic options for patients suffering from complex diseases.

Collaborations

Wang has collaborated with esteemed colleagues, including Biqin C Li and Dawn M George, who have contributed to his research endeavors and innovations.

Conclusion

Lu Wang's innovative work in immunology and oncology continues to impact the medical field significantly. His patents reflect a commitment to advancing healthcare solutions and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…